C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2009
12/29/2009	CA2321792C Nitroxyl derivatives with glycidyl or alkylcarbonyl groups as initiators for radical polymerisation
12/24/2009	US20090318705 Methods of preparing imidazole-based bicyclic compounds
12/24/2009	US20090318704 Processes for the Preparation of N-(2-Acetyl-4,6-Dimethylphenyl)-3--2-Thiophenecarboxamide
12/24/2009	US20090318690 Benzisoxazole Compound
12/24/2009	US20090318689 Processes To Make Apoptosis Promoters
12/24/2009	US20090318687 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds
12/24/2009	US20090318668 Water-Soluble CC-1065 Analogs and Their Conjugates
12/24/2009	US20090318516 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
12/24/2009	US20090318504 Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
12/24/2009	US20090318499 Compounds having analgesic and/or immunostimulant activity
12/24/2009	US20090318484 Inhibitors of JNK
12/24/2009	US20090318472 Aminopyrazine derivatives and compositions
12/24/2009	US20090318452 INHIBITORS OF p38
12/24/2009	US20090318450 Compositions for modulating a kinase cascade and methods of use thereof
12/24/2009	US20090318449 Therapeutic lactams
12/24/2009	US20090318448 Inhibitors of Bruton's Tyrosine Kinase
12/24/2009	US20090318447 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1--4-piperidinyl) methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia
12/24/2009	US20090318446 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy
12/24/2009	US20090318445 Pdf inhibitors
12/24/2009	US20090318444 Tetrahydro- and dihydroquinazolinones
12/24/2009	US20090318439 5-furopyridinone substituted indazoles
12/24/2009	US20090318438 Heterocyclic compounds and their use as anticancer agents
12/24/2009	US20090318437 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE
12/24/2009	US20090318436 Fused heterocyclic derivatives and methods of use
12/24/2009	US20090318435 Pyrazolopyridines and analogs thereof
12/24/2009	US20090318434 Composition and process - 356
12/24/2009	US20090318429 Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
12/24/2009	US20090318421 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
12/24/2009	US20090318407 Inhibitors of protein kinases
12/24/2009	US20090318405 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/24/2009	US20090318373 Receptor-type kinase modulators and methods of use
12/23/2009	WO2009155448A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/23/2009	WO2009154754A2 Synthesis of deuterated morpholine derivatives
12/23/2009	WO2009154557A1 Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
12/23/2009	WO2009154190A1 Pyridone compound
12/23/2009	WO2009153589A1 Pyridine compounds
12/23/2009	WO2009153313A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	WO2009153307A1 Compounds
12/23/2009	WO2009153238A1 Aminothiazoline compounds for combating insects, arachnids and nematodes
12/23/2009	WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	WO2009153179A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	WO2008147556A3 Melanocortin receptor ligands modified with hydantoin
12/23/2009	WO2008142550A8 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
12/23/2009	WO2008124681A4 Methods and systems for treating cell proliferation disorders
12/23/2009	EP2135873A2 Chemical coupling process with a phenyl boronic acid derivative
12/23/2009	EP2135868A1 Trans-9, 10-dehydroepothilone c and d, analogs thereof and methods of making the same
12/23/2009	EP2135867A1 Trans-9, 10-dehydroepothilone C and trans-9, 10-dehydroepothilone D, analogs thereof and methods of making the same
12/23/2009	EP2135620A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
12/23/2009	EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/23/2009	EP2134684A2 7-substituted indole mcl-1 inhibitors
12/23/2009	EP2134683A2 Novel inhibitors hepatitis c virus replication
12/23/2009	EP2134327A1 Pharmaceutical compositions of poorly soluble drugs
12/23/2009	EP1959951B1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
12/23/2009	EP1720859B1 Chemokine receptor antagonists
12/23/2009	EP1562941B1 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
12/23/2009	EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors
12/23/2009	CN101611033A Indole derivatives as S1P1 receptor agonists
12/23/2009	CN101611018A Heterocyclyc sulfonamides having Edg-I antagonistic activity
12/23/2009	CN101611014A Acylaminopyrazoles as FGFR inhibitors
12/23/2009	CN101611009A Quinoline derivatives
12/23/2009	CN101611007A Novel JNK inhibitors
12/23/2009	CN101611005A Substituted acetophenones useful as PDE4 inhibitors
12/23/2009	CN101610751A Prophylactic or therapeutic agent for alopecia
12/23/2009	CN101607959A Dihydro quinolinone derivative, preparation method thereof and medicine composition taking same as main active ingredient
12/23/2009	CN100572379C Cgrp receptor antagonists
12/23/2009	CN100572364C HIV replication inhibiting pyrimidines and triazines
12/23/2009	CA2728476A1 Heterocyclic compound and use thereof
12/23/2009	CA2728408A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
12/23/2009	CA2728156A1 Pyridone compounds
12/23/2009	CA2728054A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	CA2727251A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	CA2726746A1 Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
12/23/2009	CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	CA2726508A1 Pyridine compounds
12/22/2009	US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide
12/22/2009	US7635774 Benzimidazole derivatives
12/22/2009	US7635708 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells
12/22/2009	US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors
12/22/2009	US7635696 dopamine D2 or D3 and serotonin 5-HT1A receptors antagonist with selective serotonin reuptake inhibition (SSRI) properties; (chromeno/quinolino/benzothiopyrano/naphthaleno)[4,3-c]isoxazol derivatives; psychosis, schizophrenia, bipolar disorder; alkylation followed by reductively amination
12/22/2009	US7635695 4-Amino-2-(4-methyl-thiophen-2-yl)thieno[3,2-c]pyridine-7-carboxylic acid amide; 4-amino-2-cyclopent-1-enyl-thieno[3,2-c]pyridine-7-carboxylic acid amide; for therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease
12/22/2009	US7635694 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
12/22/2009	US7635664 For controlling undesirable plants
12/22/2009	CA2535614C Quinazoline analogs as receptor tyrosine kinase inhibitors
12/22/2009	CA2371712C Cyclothiocarbamate derivatives as progesterone receptor modulators
12/22/2009	CA2362381C Amide compounds and medicinal use thereof
12/22/2009	CA2326529C 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide
12/22/2009	CA2290744C Cyclic diamine compounds and medicine containing the same
12/18/2009	WO2008154528A2 Isoxazoline insecticides
12/17/2009	WO2009151626A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
12/17/2009	WO2009151621A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
12/17/2009	WO2009150462A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
12/17/2009	WO2009150230A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009	WO2009150144A1 New gpr119modulators
12/17/2009	WO2009150109A1 Imidazolidine derivatives
12/17/2009	WO2009150095A1 Pesticidal compositions containing a pyrandione or a thiopyrandione or a cyclohexanetrione derivative
12/17/2009	WO2009149851A1 New co-crystal compound of rivaroxaban and malonic acid
12/17/2009	WO2009149820A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009	WO2009149819A1 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009	WO2009149795A2 Heterocyclic cyclopropyl-substituted fxr binding compounds
12/17/2009	WO2009149508A1 Novel potassium channel blockers and uses thereof

1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 647